(R)-2-Amino-2'-hydroxy-1,1'-binaphthyl, 95.0%, 250mg

(R)-2-Aminopent-4-ynoic acid, 95.0%, 100g

Ethyl 2-(dimethylaminomethyl)-4-thiazolecarboxylate, 95.0%, 5g

7-BOC-5,6-DIHYDRO-8H-IMIDAZO[1,2-A]PYRAZINE-2-CARBOXYLIC ACID, 97.0%, 250mg

Spiro[benzo[e][1,3]oxazine-2,1'-cyclohexan]-4(3H)-one, 98%, 1g

2,2-Bis((R)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)acetonitrile, 97%, 100mg

n-(3-(Aminomethyl)phenyl)-N-methylmethanesulfonamide, 95%, 500mg

Ethyl 3-chloro-4-iodobenzoate, 95.0%, 5g

4-Nitrobenzyl chloride, min 98%, for synthesis, 50 g, glass packaging

4,4',4'',4'''-(1,4-Phenylenebis(azanetriyl))tetrabenzoicacid, 95%, 250mg

Famotidine>98.0%(HPLC)(T)5g

6-Bromo-8-methylquinoline, 95.0%, 5g

2-Ethoxy-5-((4-ethylpiperazin-1-yl)sulfonyl)benzoic acid, 97%, 100g